copiktra
secura bio limited - duvelisib - leukemia, lymphocytic, chronic, b-cell; lymphoma, follicular - Æxlishemjandi lyf - copiktra monotherapy is indicated for the treatment of adult patients with: relapsed or refractory chronic lymphocytic leukaemia (cll) after at least two prior therapies. follicular lymphoma (fl) that is refractory to at least two prior systemic therapies.
stimufend
fresenius kabi deutschland gmbh - pegfilgrastim - daufkyrningafæð - Ónæmisörvandi, , nýlendan að örva þáttum - lækkun á lengd mæði í tengslum og tíðni hita og mæði í tengslum í fullorðinn sjúklinga með frumudrepandi lyfjameðferð fyrir illkynja (með undantekning langvarandi merg hvítblæði og myelodysplastic heilkennum).
darunavir medical valley filmuhúðuð tafla 600 mg
medical valley invest ab - darunavir propylene glycolate - filmuhúðuð tafla - 600 mg
fluconazol krka hart hylki 150 mg
krka sverige ab - fluconazolum inn - hart hylki - 150 mg
vortemyel stungulyfsstofn, lausn 3,5 mg
zentiva k.s.* - bortezomibum inn - stungulyfsstofn, lausn - 3,5 mg
diflucan mixtúruduft, lausn 10 mg/ml
pfizer aps - fluconazolum inn - mixtúruduft, lausn - 10 mg/ml
vortil innrennslisstofn, lausn 200 mg
williams & halls ehf - voriconazolum inn - innrennslisstofn, lausn - 200 mg
darunavir medical valley filmuhúðuð tafla 800 mg
medical valley invest ab - darunavir propylene glycolate - filmuhúðuð tafla - 800 mg
bortezomib actavis stungulyfsstofn, lausn 3,5 mg
actavis group ptc ehf. - bortezomibum inn - stungulyfsstofn, lausn - 3,5 mg
candizol hart hylki 150 mg
actavis group ptc ehf. - fluconazolum inn - hart hylki - 150 mg